Logo image of NCB.DE

BANK OF AMERICA CORP (NCB.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:NCB - US0605051046 - Common Stock

45.515 EUR
+0.06 (+0.13%)
Last: 1/16/2026, 7:00:00 PM
Fundamental Rating

3

Taking everything into account, NCB scores 3 out of 10 in our fundamental rating. NCB was compared to 118 industry peers in the Banks industry. NCB has a bad profitability rating. Also its financial health evaluation is rather negative. NCB has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • In the past year NCB was profitable.
  • NCB had a positive operating cash flow in the past year.
  • Each year in the past 5 years NCB has been profitable.
  • In multiple years NCB reported negative operating cash flow during the last 5 years.
NCB.DE Yearly Net Income VS EBIT VS OCF VS FCFNCB.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B 40B 60B

1.2 Ratios

  • NCB has a Return On Assets (0.83%) which is in line with its industry peers.
  • With a Return On Equity value of 9.29%, NCB perfoms like the industry average, outperforming 41.53% of the companies in the same industry.
Industry RankSector Rank
ROA 0.83%
ROE 9.29%
ROIC N/A
ROA(3y)0.81%
ROA(5y)0.79%
ROE(3y)8.89%
ROE(5y)8.81%
ROIC(3y)N/A
ROIC(5y)N/A
NCB.DE Yearly ROA, ROE, ROICNCB.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

  • NCB's Profit Margin of 26.34% is fine compared to the rest of the industry. NCB outperforms 67.80% of its industry peers.
  • In the last couple of years the Profit Margin of NCB has declined.
  • NCB does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 26.34%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-9.96%
PM growth 5Y-2.56%
GM growth 3YN/A
GM growth 5YN/A
NCB.DE Yearly Profit, Operating, Gross MarginsNCB.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

2

2. Health

2.1 Basic Checks

  • NCB does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • NCB has less shares outstanding than it did 1 year ago.
  • NCB has less shares outstanding than it did 5 years ago.
  • NCB has a worse debt/assets ratio than last year.
NCB.DE Yearly Shares OutstandingNCB.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B
NCB.DE Yearly Total Debt VS Total AssetsNCB.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1T 2T 3T

2.2 Solvency

  • NCB has a debt to FCF ratio of 11.51. This is a negative value and a sign of low solvency as NCB would need 11.51 years to pay back of all of its debts.
  • With a decent Debt to FCF ratio value of 11.51, NCB is doing good in the industry, outperforming 74.58% of the companies in the same industry.
  • A Debt/Equity ratio of 2.33 is on the high side and indicates that NCB has dependencies on debt financing.
  • NCB's Debt to Equity ratio of 2.33 is in line compared to the rest of the industry. NCB outperforms 41.53% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.33
Debt/FCF 11.51
Altman-Z N/A
ROIC/WACCN/A
WACC10.62%
NCB.DE Yearly LT Debt VS Equity VS FCFNCB.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100B 200B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
NCB.DE Yearly Current Assets VS Current LiabilitesNCB.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200B 400B 600B

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an nice 15.77% over the past year.
  • The Earnings Per Share has been growing slightly by 3.50% on average over the past years.
  • The Revenue has grown by 8.90% in the past year. This is quite good.
  • NCB shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.23% yearly.
EPS 1Y (TTM)15.77%
EPS 3Y-0.4%
EPS 5Y3.5%
EPS Q2Q%30.86%
Revenue 1Y (TTM)8.9%
Revenue growth 3Y4.57%
Revenue growth 5Y2.23%
Sales Q2Q%10.79%

3.2 Future

  • NCB is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.96% yearly.
  • Based on estimates for the next years, NCB will show a small growth in Revenue. The Revenue will grow by 5.54% on average per year.
EPS Next Y16.91%
EPS Next 2Y15.64%
EPS Next 3Y15.45%
EPS Next 5Y13.96%
Revenue Next Year7.52%
Revenue Next 2Y6.87%
Revenue Next 3Y6.26%
Revenue Next 5Y5.54%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
NCB.DE Yearly Revenue VS EstimatesNCB.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 50B 100B 150B
NCB.DE Yearly EPS VS EstimatesNCB.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6

4

4. Valuation

4.1 Price/Earnings Ratio

  • NCB is valuated correctly with a Price/Earnings ratio of 14.40.
  • NCB's Price/Earnings ratio is rather expensive when compared to the industry. NCB is more expensive than 83.05% of the companies in the same industry.
  • NCB's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.47.
  • With a Price/Forward Earnings ratio of 12.02, NCB is valued correctly.
  • NCB's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. NCB is more expensive than 62.71% of the companies in the same industry.
  • NCB's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 24.26.
Industry RankSector Rank
PE 14.4
Fwd PE 12.02
NCB.DE Price Earnings VS Forward Price EarningsNCB.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • NCB's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. NCB is cheaper than 79.66% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.28
EV/EBITDA N/A
NCB.DE Per share dataNCB.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as NCB's earnings are expected to grow with 15.45% in the coming years.
PEG (NY)0.85
PEG (5Y)4.11
EPS Next 2Y15.64%
EPS Next 3Y15.45%

0

5. Dividend

5.1 Amount

  • NCB does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

BANK OF AMERICA CORP

FRA:NCB (1/16/2026, 7:00:00 PM)

45.515

+0.06 (+0.13%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)10-15
Earnings (Next)01-14
Inst Owners69.83%
Inst Owner ChangeN/A
Ins Owners0.1%
Ins Owner ChangeN/A
Market Cap332.37B
Revenue(TTM)107.26B
Net Income(TTM)28.25B
Analysts80.69
Price Target50.7 (11.39%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend1.05
Dividend Growth(5Y)13.83%
DP33.55%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.64%
Min EPS beat(2)2.97%
Max EPS beat(2)10.3%
EPS beat(4)4
Avg EPS beat(4)6.88%
Min EPS beat(4)2.97%
Max EPS beat(4)10.3%
EPS beat(8)8
Avg EPS beat(8)5.67%
EPS beat(12)12
Avg EPS beat(12)6.79%
EPS beat(16)16
Avg EPS beat(16)6.33%
Revenue beat(2)1
Avg Revenue beat(2)0.13%
Min Revenue beat(2)-1.41%
Max Revenue beat(2)1.67%
Revenue beat(4)3
Avg Revenue beat(4)0.35%
Min Revenue beat(4)-1.41%
Max Revenue beat(4)1.67%
Revenue beat(8)5
Avg Revenue beat(8)-0.67%
Revenue beat(12)7
Avg Revenue beat(12)-0.19%
Revenue beat(16)8
Avg Revenue beat(16)-0.17%
PT rev (1m)0.82%
PT rev (3m)9.49%
EPS NQ rev (1m)-1.38%
EPS NQ rev (3m)1.41%
EPS NY rev (1m)-0.35%
EPS NY rev (3m)3.76%
Revenue NQ rev (1m)-0.3%
Revenue NQ rev (3m)1.13%
Revenue NY rev (1m)-0.07%
Revenue NY rev (3m)0.89%
Valuation
Industry RankSector Rank
PE 14.4
Fwd PE 12.02
P/S 3.6
P/FCF 6.28
P/OCF 6.28
P/B 1.27
P/tB 1.64
EV/EBITDA N/A
EPS(TTM)3.16
EY6.94%
EPS(NY)3.79
Fwd EY8.32%
FCF(TTM)7.24
FCFY15.91%
OCF(TTM)7.24
OCFY15.91%
SpS12.64
BVpS35.83
TBVpS27.7
PEG (NY)0.85
PEG (5Y)4.11
Graham Number50.47
Profitability
Industry RankSector Rank
ROA 0.83%
ROE 9.29%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 26.34%
GM N/A
FCFM 57.31%
ROA(3y)0.81%
ROA(5y)0.79%
ROE(3y)8.89%
ROE(5y)8.81%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-9.96%
PM growth 5Y-2.56%
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 2.33
Debt/FCF 11.51
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 217.57%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score8
WACC10.62%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.77%
EPS 3Y-0.4%
EPS 5Y3.5%
EPS Q2Q%30.86%
EPS Next Y16.91%
EPS Next 2Y15.64%
EPS Next 3Y15.45%
EPS Next 5Y13.96%
Revenue 1Y (TTM)8.9%
Revenue growth 3Y4.57%
Revenue growth 5Y2.23%
Sales Q2Q%10.79%
Revenue Next Year7.52%
Revenue Next 2Y6.87%
Revenue Next 3Y6.26%
Revenue Next 5Y5.54%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y42.11%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y42.11%
OCF growth 3YN/A
OCF growth 5YN/A

BANK OF AMERICA CORP / NCB.DE FAQ

Can you provide the ChartMill fundamental rating for BANK OF AMERICA CORP?

ChartMill assigns a fundamental rating of 3 / 10 to NCB.DE.


What is the valuation status for NCB stock?

ChartMill assigns a valuation rating of 4 / 10 to BANK OF AMERICA CORP (NCB.DE). This can be considered as Fairly Valued.


What is the profitability of NCB stock?

BANK OF AMERICA CORP (NCB.DE) has a profitability rating of 3 / 10.


Can you provide the PE and PB ratios for NCB stock?

The Price/Earnings (PE) ratio for BANK OF AMERICA CORP (NCB.DE) is 14.4 and the Price/Book (PB) ratio is 1.27.


How sustainable is the dividend of BANK OF AMERICA CORP (NCB.DE) stock?

The dividend rating of BANK OF AMERICA CORP (NCB.DE) is 0 / 10 and the dividend payout ratio is 33.55%.